Replimune Group Inc (REPL)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | ASTLEY-SPARKE, PHILIP | Director | Common Stock | Disposal | 50,000 | 0 |
| Aug 17, 2026 | HILL, EMILY LUISA | Chief Financial Officer | Common Stock | Disposal | 9,256 | 14.28 |
| Aug 11, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | 2026 $0.0001 Prefunded Warrants | Acquisition | 2,609,946 | 12.06 |
| Aug 11, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | 2026 $0.0001 Prefunded Warrants | Acquisition | 126,394 | 12.06 |
| Aug 10, 2026 | PATEL, SUSHIL | Director, Chief Executive Officer | Common Stock | Disposal | 39,341 | 12.97 |
| Aug 10, 2026 | HILL, EMILY LUISA | Chief Financial Officer | Common Stock | Disposal | 11,448 | 12.97 |
| Aug 10, 2026 | XYNOS, KONSTANTINOS | Chief Medical Officer | Common Stock | Disposal | 11,447 | 12.97 |
| Aug 10, 2026 | SCHWENDENMAN, ANDREW | Chief Accounting Officer | Common Stock | Disposal | 7,632 | 12.97 |
| Jun 1, 2026 | SARCHI, CHRISTOPHER | Chief Commercial Officer | Common Stock | Disposal | 12,000 | 9.24 |
| May 18, 2026 | XYNOS, KONSTANTINOS | Chief Medical Officer | Common Stock | Disposal | 14,023 | 5.08 |
| May 18, 2026 | SCHWENDENMAN, ANDREW | Chief Accounting Officer | Common Stock | Disposal | 7,894 | 5.08 |
| May 18, 2026 | SARCHI, CHRISTOPHER | Chief Commercial Officer | Common Stock | Disposal | 8,626 | 5.08 |
| May 18, 2026 | HILL, EMILY LUISA | Chief Financial Officer | Common Stock | Disposal | 7,812 | 5.08 |
| May 18, 2026 | PATEL, SUSHIL | Director, Chief Executive Officer | Common Stock | Disposal | 37,324 | 5.08 |
| May 18, 2026 | ASTLEY-SPARKE, PHILIP | Director | Common Stock | Disposal | 17,657 | 5.08 |
| Apr 2, 2026 | SARCHI, CHRISTOPHER | Chief Commercial Officer | Common Stock | Disposal | 6,500 | 8.01 |
| Apr 1, 2026 | OLIGER, CHRISTY J. | Director | Stock Option (right to buy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | WEINAND, DIETER | Director | Stock Option (right to buy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Non-Qualified Stock Option (right to buy)uy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | PATEL, SUSHIL | Director, Chief Executive Officer | Employee Stock Option (right to buy) | Acquisition | 376,860 | 0 |
| Apr 1, 2026 | HILL, EMILY LUISA | Chief Financial Officer | Employee Stock Option (right to buy) | Acquisition | 75,000 | 0 |
| Apr 1, 2026 | XYNOS, KONSTANTINOS | Chief Medical Officer | Common Stock | Acquisition | 50,000 | 0 |
| Apr 1, 2026 | ASTLEY-SPARKE, PHILIP | Director | Common Stock | Acquisition | 50,000 | 0 |
| Apr 1, 2026 | SLATTERY, JOSEPH P | Director | Stock Option (right to buy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | PATEL, SUSHIL | Director, Chief Executive Officer | Common Stock | Acquisition | 251,240 | 0 |
| Apr 1, 2026 | HILL, EMILY LUISA | Chief Financial Officer | Common Stock | Acquisition | 50,000 | 0 |
| Apr 1, 2026 | DHINGRA, KAPIL | Director | Stock Option (right to buy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | SCHWENDENMAN, ANDREW | Chief Accounting Officer | Common Stock | Disposal | 36,667 | 0 |
| Apr 1, 2026 | SARCHI, CHRISTOPHER | Chief Commercial Officer | Employee Stock Option (right to buy) | Acquisition | 75,000 | 0 |
| Apr 1, 2026 | PEEPLES-DYER, VELEKA | Director | Stock Option (right to buy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | ASTLEY-SPARKE, PHILIP | Director | Stock Option (right to buy) | Acquisition | 75,000 | 0 |
| Apr 1, 2026 | PUCCI, PAOLO | Director | Stock Option (right to buy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | SARCHI, CHRISTOPHER | Chief Commercial Officer | Common Stock | Acquisition | 50,000 | 0 |
| Apr 1, 2026 | SCHWENDENMAN, ANDREW | Chief Accounting Officer | Employee Stock Option (right to buy) | Acquisition | 55,000 | 0 |
| Apr 1, 2026 | BALACHANDRAN, MADHAVAN | Director | Stock Option (right to buy) | Acquisition | 44,500 | 0 |
| Apr 1, 2026 | XYNOS, KONSTANTINOS | Chief Medical Officer | Employee Stock Option (right to buy) | Acquisition | 75,000 | 0 |
| Feb 18, 2026 | ASTLEY-SPARKE, PHILIP | Director | Common Stock | Disposal | 25,000 | 0 |
| Dec 19, 2025 | XYNOS, KONSTANTINOS | Chief Medical Officer | Common Stock | Acquisition | 60,000 | 0 |
| Dec 19, 2025 | SCHWENDENMAN, ANDREW | Chief Accounting Officer | Common Stock | Acquisition | 10,000 | 0 |
| Dec 19, 2025 | HILL, EMILY LUISA | Chief Financial Officer | Common Stock | Acquisition | 60,000 | 0 |
| Dec 19, 2025 | SARCHI, CHRISTOPHER | Chief Commercial Officer | Common Stock | Acquisition | 35,000 | 0 |
| Dec 19, 2025 | PATEL, SUSHIL | Director, Chief Executive Officer | Common Stock | Acquisition | 200,000 | 0 |
| Dec 9, 2025 | DHINGRA, KAPIL | Director | Common Stock | Disposal | 3,169 | 10.4 |
| Dec 9, 2025 | DHINGRA, KAPIL | Director | Stock Option (right to buy) | Disposal | 3,169 | 0 |
| Dec 9, 2025 | DHINGRA, KAPIL | Director | Common Stock | Acquisition | 3,169 | 1.75 |
| Dec 2, 2025 | PATEL, SUSHIL | Director, Chief Executive Officer | Common Stock | Disposal | 10,000 | 11.13 |
| Nov 17, 2025 | SARCHI, CHRISTOPHER | Chief Commercial Officer | Common Stock | Disposal | 5,208 | 9.1 |
| Nov 17, 2025 | XYNOS, KONSTANTINOS | Chief Medical Officer | Common Stock | Disposal | 7,248 | 9.1 |